Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion type Assertion NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_head.
- NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion wasGeneratedBy ECO_0000203 NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_provenance.
- NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion wasDerivedFrom befree-20150227 NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_provenance.
- NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion SIO_000772 8309256 NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_provenance.
- NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion evidence source_evidence_literature NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_provenance.
- NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_assertion description "[These results suggest that the t(11;17) (PLZF/RAR alpha) case of this study was less responsive to ATRA therapy than t(15;17) (PML/RAR alpha) cases and raises the question of the definition of this novel AML subtype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954816.RA2v2YNAlrDa-dSZ0OUiUK6WtNEcTDAmhz4aq1Hb4ldiA130_provenance.